Ovarian Cancer

According to the American Cancer Society, women have a 1 in 75 of developing ovarian cancer in their lifetimes.

About half of all women who are diagnosed with ovarian cancer are 63 years old or older. 

GoPath has developed several molecular tests to diagnose ovarian cancer and predict prognosis. We also offer hereditary testing to determine if there is a familial link to ovarian cancer that may be passed from generation to generation. 

These tests include:

          •     Ovarian Panel - Examines BRAF, KRAS and PIK3CA genes for mutations for better insight into cancer
          •     BRCAnow® for Hereditary Breast and Ovarian Cancer (includes breast, ovarian, prostate, pancreatic and melanoma)
          •     OncoTargetTM - Detects genetic mutations in a tumor that may lead to treatment resistance
          •     Ovarian Biopsy